Skip to main content
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. logo

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. — Investor Relations & Filings

Ticker · 000661 ISIN · CNE0000007J8 LEI · 300300X04OTKZG18WD66 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2022-09-29 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000661

About CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.

https://ccht.jl.cn

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. is a diversified enterprise primarily focused on the research, development, production, and distribution of biopharmaceuticals and healthcare products. The company operates through several key subsidiaries, most notably GeneScience Pharmaceuticals, which specializes in recombinant human growth hormones and pediatric endocrinology treatments. Its product portfolio includes biological drugs, vaccines, and traditional Chinese medicines, targeting therapeutic areas such as growth disorders, infectious diseases, and oncology. The group emphasizes technological innovation and maintains a significant presence in the domestic market while expanding its international footprint. In addition to its core life sciences business, the company maintains interests in real estate development and infrastructure management.

Recent filings

Filing Released Lang Actions
中信建投证券、中天国富证券关于长春高新发行股份及可转换债券购买资产并募集配套资金暨关联交易之标的资产减值测试情况的核查意见
Audit Report / Information Classification · 95% confidence The document is a verification opinion from independent financial advisors regarding the impairment test of assets related to a major asset restructuring involving issuance of shares and convertible bonds by Changchun High-tech Industry (Group) Co., Ltd. It includes detailed discussion of impairment testing, valuation, and compensation agreements. The document is not a full annual or interim report, nor is it a simple announcement. It is a specialized audit-related verification report on asset impairment testing tied to a major asset restructuring transaction. This fits the definition of an Audit Report / Information (AR), as it is a standalone audit-related report focusing on impairment testing results and compliance with regulatory requirements for asset restructuring. The document length is short (1521 characters), but it contains substantive audit verification content, not just an announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2021
2022-09-29 Chinese
关于向激励对象授予预留限制性股票与股票期权的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the granting of reserved restricted stocks and stock options to incentive recipients by Changchun High-tech Industry (Group) Co., Ltd. It includes specifics about the stock option plan, approval procedures, performance assessment criteria, accounting treatment, and the impact on financials. The content focuses on the company's stock incentive plan, including the number of shares/options granted, prices, vesting schedules, performance targets, and regulatory compliance. This type of document is a formal announcement related to capital/financing activities, specifically about stock-based compensation and equity incentives. It is not a full financial report, audit report, or earnings release, nor is it a regulatory filing or a proxy statement. It fits best under the category of Capital/Financing Update (CAP) because it updates on the company's equity incentive plan and related capital structure changes.
2022-09-29 Chinese
第十届监事会第十一次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Changchun High-tech Industry Group Co., Ltd. It details the meeting date, attendance, and the approval of specific proposals related to stock incentives and impairment testing reports. The document is short (1489 characters) and primarily serves as an official announcement of the Supervisory Board's decisions rather than a full report or detailed financial statement. It does not contain comprehensive financial data or detailed management discussion. Therefore, it fits best as a Regulatory Filing (RNS), which is a general category for regulatory announcements that do not fit other specific categories.
2022-09-29 Chinese
深圳价值在线咨询顾问有限公司关于长春高新技术产业（集团）股份有限公司2022年限制性股票与股票期权激励计划预留授予相关事项之独立财务顾问报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Independent Financial Advisor Report" related to a 2022 restricted stock and stock option incentive plan for Changchun High-tech Industry (Group) Co., Ltd. It is issued by Shenzhen Value Online Consulting Co., Ltd. The content includes detailed definitions, approval procedures, specific grant details, conditions for grant and vesting, performance targets, and other related information about the stock incentive plan. The document is comprehensive and contains substantive financial and procedural data related to the incentive plan. It is not a brief announcement or a certification letter, but a full advisory report on the incentive plan. This type of document fits best under the category of Audit Report / Information (AR), as it is a standalone advisory report related to accounting and financial incentives, not a full annual or quarterly report, nor a regulatory filing or announcement. Therefore, the classification is AR with high confidence. FY 2022
2022-09-29 Chinese
重大资产重组标的资产减值测试专项审核报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Audit Report" (审 核 报 告) issued by a certified public accounting firm (大信会计师事务所) regarding a specific asset impairment test related to a major asset restructuring (重大资产重组标的资产减值测试). It includes detailed audit responsibilities, management responsibilities, and audit opinions. The document references regulatory guidelines from the China Securities Regulatory Commission and contains detailed financial and operational information about the asset and related agreements. It is not a full annual or interim report but a standalone audit report focused on the impairment test of the asset involved in a major restructuring. The length and content confirm it is a substantive audit report rather than a brief announcement or certification. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2021
2022-09-29 Chinese
重大资产重组标的资产业绩承诺期满2021年12月31日减值测试报告
Audit Report / Information Classification · 95% confidence The document is titled as a "减值测试报告" which translates to "Impairment Test Report" related to a major asset restructuring. It details the background of the asset acquisition, the performance commitments, the impairment testing methodology, and the conclusion that no impairment occurred as of December 31, 2021. The document includes detailed financial and operational information about the asset and the related parties, as well as the approval by the board. It is a standalone report focused on the audit and valuation of the asset's impairment status, not a full annual or interim report, nor an announcement or presentation. This fits the definition of an Audit Report / Information (AR) as it contains results of an internal or regulatory stress test (impairment test) and applied accounting principles related to the asset reorganization. The document length is sufficient and contains substantive financial data and analysis, not merely a notice or certification. Therefore, the appropriate classification is AR with high confidence. FY 2021
2022-09-29 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.